Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2015:2015:346812.
doi: 10.1155/2015/346812. Epub 2015 Dec 22.

A Narrative Review on the Pathophysiology and Management for Radiation Cystitis

C Browne  1 , N F Davis  1 , E Mac Craith  1 , G M Lennon  1 , D W Mulvin  1 , D M Quinlan  1 , Gerard P Mc Vey  2 , D J Galvin  1
Affiliations
Review

A Narrative Review on the Pathophysiology and Management for Radiation Cystitis

C Browne et al. Adv Urol. 2015.

Abstract

Radiation cystitis is a recognised complication of pelvic radiotherapy. Incidence of radiation cystitis ranges from 23 to 80% and the incidence of severe haematuria ranges from 5 to 8%. High quality data on management strategies for radiation cystitis is sparse. Treatment modalities are subclassified into systemic therapies, intravesical therapies, and hyperbaric oxygen and interventional procedures. Short-term cure rates range from 76 to 95% for hyperbaric oxygen therapy and interventional procedures. Adverse effects of these treatment strategies are acceptable. Ultimately, most patients require multimodal treatment for curative purposes. Large randomised trials exploring emergent management strategies are required in order to strengthen evidence-based treatment strategies. Urologists encounter radiation cystitis commonly and should be familiar with diagnostic modalities and treatment strategies.

PubMed Disclaimer

References

    1. Marks L. B., Carroll P. R., Dugan T. C., Anscher M. S. The response of the urinary bladder, urethra, and ureter to radiation and chemotherapy. International Journal of Radiation Oncology, Biology, Physics. 1995;31(5):1257–1280. doi: 10.1016/0360-3016(94)00431-j. - DOI - PubMed
    1. Sutani S., Ohashi T., Sakayori M., et al. Comparison of genitourinary and gastrointestinal toxicity among four radiotherapy modalities for prostate cancer: conventional radiotherapy, intensity-modulated radiotherapy, and permanent iodine-125 implantation with or without external beam radiotherapy. Radiotherapy and Oncology. 2015;117(2):270–276. doi: 10.1016/j.radonc.2015.08.019. - DOI - PubMed
    1. Kole T. P., Tong M., Wu B., et al. Late urinary toxicity modeling after stereotactic body radiotherapy (SBRT) in the definitive treatment of localized prostate cancer. Acta Oncologica. 2015:1–7. doi: 10.3109/0284186x.2015.1037011. - DOI - PMC - PubMed
    1. Sveistrup J., af Rosenschöld P. M., Deasy J. O., et al. Improvement in toxicity in high risk prostate cancer patients treated with image-guided intensity-modulated radiotherapy compared to 3D conformal radiotherapy without daily image guidance. Radiation Oncology. 2014;9(1, article 44) doi: 10.1186/1748-717x-9-44. - DOI - PMC - PubMed
    1. Fonteyne V., Villeirs G., Lumen N., De Meerleer G. Urinary toxicity after high dose intensity modulated radiotherapy as primary therapy for prostate cancer. Radiotherapy and Oncology. 2009;92(1):42–47. doi: 10.1016/j.radonc.2009.03.013. - DOI - PubMed

LinkOut - more resources